INSERM, U1052, Cancer Research Center of Lyon (CRCL), Université de Lyon (UCBL1), CNRS UMR_5286, France; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
INSERM, U1052, Cancer Research Center of Lyon (CRCL), Université de Lyon (UCBL1), CNRS UMR_5286, France.
J Hepatol. 2019 Dec;71(6):1086-1098. doi: 10.1016/j.jhep.2019.06.032. Epub 2019 Jul 23.
BACKGROUND & AIMS: Liver macrophages can be involved in both pathogen clearance and/or pathogenesis. To get further insight on their role during chronic hepatitis B virus (HBV) infections, our aim was to phenotypically and functionally characterize in vivo and ex vivo the interplay between HBV, primary human liver macrophages (PLMs) and primary blood monocytes differentiated into pro-inflammatory or anti-inflammatory macrophages (M1-MDMs or M2-MDMs, respectively).
PLMs or primary blood monocytes, either ex vivo differentiated into M1-MDMs or M2-MDMs, were exposed to HBV and their activation followed by ELISA or quantitative reverse transcription PCR (RT-qPCR). Liver biopsies from HBV-infected patients were analysed by RT-qPCR or immunohistochemistry. Viral parameters in HBV-infected primary human hepatocytes and differentiated HepaRG cells were followed by ELISA, qPCR and RT-qPCR analyses.
HBc protein was present within the macrophages of liver biopsies taken from HBV-infected patients. Macrophages from HBV-infected patients also expressed higher levels of anti-inflammatory macrophage markers than those from non-infected patients. Ex vivo exposure of naive PLMs to HBV led to reduced secretion of pro-inflammatory cytokines. Upon exposure to HBV or HBV-producing cells during differentiation and activation, M1-MDMs secreted less IL-6 and IL-1β, whereas M2-MDMs secreted more IL-10 when exposed to HBV during activation. Finally, cytokines produced by M1-MDMs, but not those produced by HBV-exposed M1-MDMs, decreased HBV infection of hepatocytes.
Altogether, our data strongly suggest that HBV modulates liver macrophage functions to favour the establishment of infection.
Hepatitis B virus modulates liver macrophage function in order to favour the establishment and likely maintenance of infection. It impairs the production of the antiviral cytokine IL-1β, while promoting that of IL-10 in the microenvironment. This phenotype can be recapitulated in naive liver macrophages or monocyte-derived-macrophages ex vivo by short exposure to the virus or cells replicating the virus, thus suggesting an "easy to implement" mechanism of inhibition.
肝脏巨噬细胞可参与病原体清除和/或发病机制。为了进一步了解其在慢性乙型肝炎病毒(HBV)感染过程中的作用,我们的目的是表型和功能上描述体内和体外 HBV 与原代人肝巨噬细胞(PLM)和原代血单核细胞分化为促炎或抗炎巨噬细胞(M1-MDMs 或 M2-MDMs)之间的相互作用。
PLM 或原代血单核细胞,无论是体外分化为 M1-MDMs 还是 M2-MDMs,均暴露于 HBV 下,并通过 ELISA 或定量逆转录 PCR(RT-qPCR)检测其激活情况。通过 RT-qPCR 或免疫组织化学分析 HBV 感染患者的肝活检组织。通过 ELISA、qPCR 和 RT-qPCR 分析检测 HBV 感染的原代人肝细胞和分化的 HepaRG 细胞中的病毒参数。
HBc 蛋白存在于 HBV 感染患者肝活检组织的巨噬细胞内。与非感染患者相比,HBV 感染患者的巨噬细胞表达更高水平的抗炎巨噬细胞标志物。PLM 对 HBV 的体外暴露导致促炎细胞因子分泌减少。在分化和激活过程中暴露于 HBV 或产生 HBV 的细胞时,与暴露于 HBV 激活时相比,M1-MDMs 分泌的 IL-6 和 IL-1β 较少,而 M2-MDMs 分泌的 IL-10 较多。最后,M1-MDMs 产生的细胞因子而非暴露于 HBV 的 M1-MDMs 产生的细胞因子可降低 HBV 对肝细胞的感染。
综上所述,我们的数据强烈表明 HBV 调节肝巨噬细胞功能以利于感染的建立。
HBV 调节肝巨噬细胞功能以利于感染的建立和可能的维持。它抑制抗病毒细胞因子 IL-1β 的产生,同时促进微环境中 IL-10 的产生。这种表型可通过病毒或复制病毒的细胞的短暂暴露在体外的原代肝巨噬细胞或单核细胞衍生的巨噬细胞中重现,因此提示了一种“易于实施”的抑制机制。